SNAP-8 peptide: the Argireline relative with almost no independent data

SNAP-8 is the trade name a cosmetic ingredient supplier uses for acetyl octapeptide-3, a lab-made chain of eight amino acids sold to soften expression lines such as crow’s feet. It is a cosmetic ingredient, not an FDA-approved drug, and FDA does not review cosmetics for effectiveness. We found no peer-reviewed study that tested it on its own, so its reputation rests on supplier claims and on studies of a shorter relative. The skincare peptides index has the wider set, and the peptide serum guide shows where this peptide fits.

What is SNAP-8?

SNAP-8 is acetyl hexapeptide-8, better known by the trade name Argireline, with two amino acids added to the end.

The added amino acids are alanine and aspartic acid. Both peptides are modeled on the start of SNAP-25, a nerve-cell protein that helps release acetylcholine, the chemical messenger that makes muscles contract. The supplier describes SNAP-8 as competing with SNAP-25 “for a position in the SNARE complex, essential for the muscle contraction.” The SNARE complex is the protein machinery that botulinum toxin disrupts, which is why these peptides are marketed as “Botox-like.”

Does SNAP-8 work?

Nobody independent has shown that it does. That is different from showing it fails: the test has simply not been published.

Supplier data

The supplier’s listing describes SNAP-8 as a “premium topical alternative to botulinum toxin injections,” says it acts against “persistent expression wrinkles” and claims “up to 56% roughness reduction.” The listing does not say how many people were tested, for how long, against what control, or whether the results were peer reviewed. Larger wrinkle-reduction figures repeated on retail and blog sites could not be traced to any published study, so this page does not repeat them.

Published human studies

A PubMed search for acetyl octapeptide-3, SNAP-8 and acetyl glutamyl heptapeptide on November 2, 2026 returned two records. Both tested multi-ingredient microneedle patches rather than a serum.

Neither study can say what acetyl octapeptide-3 did on its own, because each product combined it with other actives. Both used microneedles, which push ingredients past the skin barrier in a way a serum does not. Both had authors from companies in the microneedle patch business. So a figure like 25.8% describes a whole patch, and it should not be read as a SNAP-8 result, let alone a serum result.

SNAP-8 vs Argireline

Argireline has the longer record, and that record is mixed. Because SNAP-8 is marketed as an extension of acetyl hexapeptide-8, the shorter peptide is the closest guide to what to expect.

• The shorter peptide has more studies. A 2002 developer study in 10 women reported wrinkle depth down up to 30% after 30 days. A 2013 randomized trial in 60 adults found 48.9% judged improved, compared with 0% on placebo, after 4 weeks.
• Not every study is positive. An independent 2023 double-blind split-face study of 19 women found no significant difference between a serum with acetyl hexapeptide-8 and the same serum without it.
• Getting into skin is the problem. In an FDA laboratory study, 99.7% of acetyl hexapeptide-8 applied in a cosmetic emulsion washed off the surface, and none reached the dermis. A 2025 review concluded that delivering it to muscle through the skin “is likely impossible.” The octapeptide is about 20% heavier, and we found no published study of how well it penetrates.
• A head-to-head comparison does not exist. We found no published study comparing acetyl octapeptide-3 with acetyl hexapeptide-8.
• Safety review. The Cosmetic Ingredient Review panel concluded acetyl hexapeptide-8 is safe in cosmetics “at concentrations up to 0.005%” and that data were insufficient above that. We found no equivalent assessment for acetyl octapeptide-3.

SNAP-8 vs Botox

No published study compares them, and they are not the same kind of product. Botox Cosmetic is an FDA-approved drug injected into muscle. A SNAP-8 serum is a cosmetic that sits on the skin.

The author of the 2023 split-face study reached the same place for the shorter peptide, concluding that it is no alternative to botulinum toxin. The peptide’s own developers wrote that its efficacy was much lower than the toxin’s. If you have seen “Botox in a bottle” on a label, that is a marketing line, and no published data support it.

What has stronger evidence for lines?

If you want softer lines and are weighing a serum, these have firmer evidence behind them.

A serum can still be a reasonable personal choice. It simply has much less behind it.

How much is in a product?

Very little peptide. The supplier sells SNAP-8 as a water-based solution containing 0.05% acetyl octapeptide-3 and suggests using 3% to 10% of that solution in a finished product. That works out to roughly 0.0015% to 0.005% of the peptide itself. A figure such as “10% SNAP-8” on a bottle refers to the solution; at the supplier’s stated strength that is about 0.005% peptide.

On an ingredient list, look for acetyl octapeptide-3, because SNAP-8 is a trade name and may appear only on the front of the pack. The supplier’s listing gives the ingredient as acetyl octapeptide-3 with caprylyl glycol. US rules let ingredients at 1% or less appear in any order after those above 1%, so position on the list does not show the amount. The guide to choosing a peptide serum explains what else a label can tell you.

How to read a SNAP-8 claim

When a brand quotes a percentage for SNAP-8, three questions usually settle it. Does the number come from a published study, or from a supplier sheet with no study details? Did the test use the peptide alone, or a mixture? A 2017 review warned that with mixtures the results “cannot be claimed clearly to be the effect of the used peptide.” And was it a serum, or a microneedle patch? If a brand cannot answer those, the figure tells you nothing about the bottle in your hand.

Can you use SNAP-8 with retinol, vitamin C or Argireline?

We found no published study of these combinations, for benefit or harm. Serums that pair SNAP-8 with acetyl hexapeptide-8 are making an untested assumption that the two add up. The American Academy of Dermatology (AAD) advises starting one anti-aging product at a time, because several at once can irritate skin.

Side effects and irritation

The two patch studies reported no skin reactions or adverse effects. Neither was designed to detect rare reactions, and we found no formal safety assessment of this peptide. The AAD suggests testing any new product on a quarter-sized spot twice daily for 7 to 10 days, and advises stopping one that stings, burns or tingles. Any vial or powder labeled “research use only”, whatever the peptide, is not legal to use on people.

How long would it take to see a change?

No study of SNAP-8 alone can answer that. The AAD says most anti-aging products take at least six weeks and sometimes up to three months. The patch studies ran 28 days and 12 weeks, but microneedles make those timelines a poor guide to a serum.

The bottom line on evidence

SNAP-8 is a plausible idea with almost no independent data. Its relative, acetyl hexapeptide-8, has small and mixed human studies and a penetration problem. Under US law the supplier and the brand are responsible for safety, and no one is required to prove to FDA that a cosmetic works. For the broader evidence on aging skin, see peptides for skin.